Katri Lindfors

Aktiviteetit

Aktiviteetteja vuodessa 2003 2009 2010 2011 2012 2013 2019 2022

• 172 Konferenssiesitelmä
• 29 Tieteellisen lehden refereenä toimiminen
• 14 Maisteriopiskelijoiden ohjaaminen
• 7 Väitöskirjatutkijan ohjaaja
• 41 Lisää
  • 7 Kutsuttu esitelmä
  • 6 Väitöskirjan esitarkastajana tai vastaväittäjänä toimiminen
  • 5 Jäsenyys seurassa tai verkostossa
  • 5 Nimitetty asiantuntija- tai luottamustehtävä rahoittajaorganisaatioissa
  • 4 Esiintyminen mediassa
  • 3 Lääketieteen lisensiaattitutkielman tekijän ohjaaja
  • 2 Workshopin tai sessionin puheenjohtajana toimiminen
  • 2 Konferenssin tai seminaarin järjestelytoimikunnan jäsenyys
  • 2 Julkinen esitelmä
  • 1 Konferenssin tai seminaarin tieteellisen tai ohjelmatoimikunnan jäsenyys
  • 1 Konsultointi
  • 1 Nimitetty asiantuntija- tai luottamustehtävä seurassa tai verkostossa
  • 1 Akateeminen pätevyys (esim. dosentin arvo)
  • 1 Tieteellisen ohjelman tai projektin johtaminen

Aktiviteetteja vuodessa

Hakutulokset

• Are transglutaminase 2 inhibitors able to decrease gliadin-induced toxicity related to coeliac disease? A proof-of-concept study

  Tiina Rauhavirta (Speaker), Katri Kaukinen (Speaker), Katri Lindfors (Speaker) & Markku Mäki (Speaker)

  22 marrask. 2011

  Aktiviteetti: Konferenssiesitelmä

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  Laura Airaksinen (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Johanna Schleutker (Contributor)

  22 marrask. 2011

  Aktiviteetti: Konferenssiesitelmä

• Are TG2 inhibitors able to decrease gliadin-induced toxicity related to coeliac disease?

  Tiina Rauhavirta (Contributor), Rami Kivistö (Contributor), Ilma Korponay-Szabó (Contributor), Pekka T Männistö (Contributor), J. Arturo Garcia-Horsman (Contributor), Mongeot Alexandre (Contributor), Russell Collighan (Contributor), Martin Griffin (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor) & Katri Lindfors (Contributor)

  22 kesäk. 2011

  Aktiviteetti: Konferenssiesitelmä

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  Laura Airaksinen (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Johanna Schleutker (Contributor)

  20 kesäk. 2011

  Aktiviteetti: Konferenssiesitelmä

• Superior performance of transglutaminase 2 antibody assay against open conformation of the enzyme in celiac disease

  Katri Lindfors (Speaker), Outi Koskinen (Speaker), Kalle Kurppa (Speaker), Kaija Laurila (Speaker), Pekka Collin (Speaker), Katri Haimila (Speaker), Jukka Partanen (Speaker), Päivi Saavalainen (Speaker), Markku Mäki (Speaker) & Katri Kaukinen (Speaker)

  20 kesäk. 2011

  Aktiviteetti: Konferenssiesitelmä

• Serum markers suitable for the study ond early recognition of celiac disease

  Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor), Alina Popp (Contributor) & Mauno Vihinen (Contributor)

  13 kesäk. 2011

  Aktiviteetti: Konferenssiesitelmä

• Celiac patient transglutaminase 2-targeted autoantibodies inhibit in vivo angiogenesis likely through overexpression of RhoB

  Katri Lindfors (Contributor), Sergio Caja (Contributor), Stefanie Martucciello (Contributor), Miha Lavric (Contributor), Ilma Korponay-Szabo (Contributor), Cristina Nadalutti (Contributor), Tiina Rauhavirta (Contributor), Carla Esposito (Contributor), Ana-Marija Sulic (Contributor), Daniele Sblattero (Contributor), Roberto Marzari (Contributor), Markku Mäki (Contributor) & Katri Kaukinen (Contributor)

  28 toukok. 2011

  Aktiviteetti: Konferenssiesitelmä

• Celiac Patient Transglutaminase 2-Targeted Autoantibodies Inhibit in Vivo Angiogenesis Likely Through Overexpression of RhoB

  Katri Lindfors (Speaker), Sergio Caja (Speaker), Stefanie Martucciello (Speaker), Miha Lavric (Speaker), Ilma Korponay-Szabo (Speaker), Cristina Nadalutti (Speaker), Tiina Rauhavirta (Speaker), Carla Esposito (Speaker), Ana-Marija Sulic (Speaker), Daniele Sblattero (Speaker), Roberto Marzari (Speaker), Markku Mäki (Speaker) & Katri Kaukinen (Speaker)

  28 toukok. 2011

  Aktiviteetti: Konferenssiesitelmä

• Treatment of screen-Detected and asymptomatic coeliac disease patients. A randomized clinical trial

  Kalle Kurppa (Contributor), Pekka Collin (Contributor), Heini Huhtala (Contributor), Katri Kaukinen (Contributor), Kaija Laurila (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  26 toukok. 2011

  Aktiviteetti: Konferenssiesitelmä

• Are TG2 inhibitors able to decrease gliadin-induced toxicity related to celiac disease? A proof-of-concept study

  Katri Lindfors (Speaker), Tiina Rauhavirta (Speaker), Rami Kivistö (Speaker), Pekka Männistö (Speaker), Arturo Garcia-Horsman (Speaker), Martin Griffin (Speaker), Markku Mäki (Speaker) & Katri Kaukinen (Speaker)

  26 toukok. 2011

  Aktiviteetti: Konferenssiesitelmä

• Are TG2 inhibitors able to decrease gliadin-induced toxicity related to celiac disease – a proof-of-concept study

  Katri Lindfors (Contributor), Katri Kaukinen (Contributor), Markku Mäki (Contributor) & Tiina Rauhavirta (Contributor)

  9 toukok. 2011

  Aktiviteetti: Konferenssiesitelmä

• Overexpression of RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies

  Katri Lindfors (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Markku Mäki (Contributor), Cristina Nadalutti (Contributor) & Tiina Rauhavirta (Contributor)

  9 toukok. 2011

  Aktiviteetti: Konferenssiesitelmä

• Should screen-detected and asymptomatic celiac disease patients be treated? A prospective and randomized trial

  Kalle Kurppa (Contributor), Pekka Collin (Contributor), Heini Huhtala (Contributor), Katri Kaukinen (Contributor), Kaija Laurila (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  9 toukok. 2011

  Aktiviteetti: Konferenssiesitelmä

• Coeliac disease-specific autoantibodies targeted against transglutaminase 2 inhibit vasculature in vitro and in vivo through Rho B

  Suvi Kalliokoski (Contributor), Stefania Martucciello (Contributor), Miha Lavric (Contributor), Cristina Nadalutti (Contributor), Rafael Frias (Contributor), Ana-Marija Sulic (Contributor), Carla Esposito (Contributor), Lauri Pelliniemi (Contributor), Anne Roivainen (Contributor), Daniele Sblattero (Contributor), Roberto Marzari (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Sergio Caja (Contributor)

  19 tammik. 2011

  Aktiviteetti: Konferenssiesitelmä

• Passive transfer of celiac disease into mice – Part II

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  19 tammik. 2011

  Aktiviteetti: Konferenssiesitelmä

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  Laura Airaksinen (Contributor), Katri Kaukinen (Contributor), Johanna Schleutker (Contributor), Päivi Saavalainen (Contributor), Markku Mäki (Contributor) & Katri Lindfors (Contributor)

  19 tammik. 2011

  Aktiviteetti: Konferenssiesitelmä

• Are TG2 inhibitors able to decrease gliadin-induced toxicity related to coeliac disease? – a proof-of-concept study

  T Rauhavirta (Speaker), R Kivistö (Speaker), K Kaukinen (Speaker), I Korponay-Szabo (Speaker), PT Männistö (Speaker), JA Garcia-Horsman (Speaker), A Mongeot (Speaker), R Collighan (Speaker), M Griffin (Speaker), M Mäki (Speaker) & K Lindfors (Speaker)

  15 jouluk. 2010

  Aktiviteetti: Konferenssiesitelmä

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  L Airaksinen (Contributor), K Kaukinen (Contributor), J Schleutker (Contributor), P Saavalainen (Contributor), M Mäki (Contributor) & K Lindfors (Contributor)

  15 jouluk. 2010

  Aktiviteetti: Konferenssiesitelmä

• Passive transfer of celiac disease into mice - Part II

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  15 jouluk. 2010

  Aktiviteetti: Konferenssiesitelmä

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  L Airaksinen (Contributor), K Kaukinen (Contributor), J Schleutker (Contributor), M Mäki (Contributor) & K Lindfors (Contributor)

  10 syysk. 2010

  Aktiviteetti: Konferenssiesitelmä

• Epithelial transport and deamidation of gliadin peptides - a role for coeliac disease patient IgA

  T Rauhavirta (Contributor), S-W Qiao (Contributor), Z Jiang (Contributor), E Myrsky (Contributor), J Loponen (Contributor), IR Korponay-Szabó (Contributor), H Salovaara (Contributor), JA Garcia-Horsman (Contributor), J Venäläinen (Contributor), PT Männistö (Contributor), R Collighan (Contributor), A Mongeot (Contributor), M Griffin (Contributor), M Mäki (Contributor), K Kaukinen (Contributor) & K Lindfors (Contributor)

  10 syysk. 2010

  Aktiviteetti: Konferenssiesitelmä

• Celiac patient autoantibodies against transglutaminase 2 disturb angiogenesis in vitro and in vivo

  Sergio Caja (Contributor), Cristina Nadalutti (Contributor), Suvi Kalliokoski (Contributor), Essi Myrsky (Contributor), Anne Roivainen (Contributor), Lauri Pelliniemi (Contributor), Rafael Frias (Contributor), Anamaria Sulic (Contributor), Miha Lavric (Contributor), Daniele Sblattero (Contributor), Roberto Marzari (Contributor), Mongeot Alexandre (Contributor), Russell Collighan (Contributor), Martin Griffin (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor) & Katri Lindfors (Contributor)

  19 heinäk. 2010

  Aktiviteetti: Konferenssiesitelmä

• Gliadin induced apoptosis in T84 three dimensional cell model

  A. Castellanos-Rubi (Contributor), JR. Bilbao (Contributor), Katri Kaukinen (Contributor), Markku Mäki (Contributor) & Katri Lindfors (Contributor)

  11 kesäk. 2010

  Aktiviteetti: Konferenssiesitelmä

• Identification of the disease-specific coeliac epitope of transglutaminase 2 and possible antibody-based therapy

  Katri Lindfors (Speaker), Ilma Korponay-Szabó (Speaker) & Markku Mäki (Speaker)

  10 kesäk. 2010

  Aktiviteetti: Konferenssiesitelmä

• Detoxification of gluten by germinating cereal enzymes: Implications for new treatment of coeliac disease

  Katri Lindfors (Contributor), Katri Kaukinen (Contributor) & Markku Mäki (Contributor)

  8 kesäk. 2010

  Aktiviteetti: Konferenssiesitelmä

• Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb vessel morphogenesis in vitro and in vivo

  S Caja (Speaker), S Martucciello (Speaker), M Lavric (Speaker), D Sblattero (Speaker), R Marzari (Speaker), M Mäki (Speaker), K Kaukinen (Speaker) & K Lindfors (Speaker)

  20 tammik. 2010

  Aktiviteetti: Konferenssiesitelmä

• Features of celiac disease can be induced in mice by passive transfer of patient serum

  Suvi Kalliokoski (Contributor), Sergio Caja (Contributor), Ilma R. Korponay-Szabó (Contributor), Outi Koskinen (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor) & Katri Lindfors (Contributor)

  20 tammik. 2010

  Aktiviteetti: Konferenssiesitelmä

• Downregulation of tissue transglutaminase and its implications for coeliac disease

  C Nadalutti (Speaker), K Viiri (Speaker), K Kaukinen (Speaker), M Mäki (Speaker) & K Lindfors (Speaker)

  20 tammik. 2010

  Aktiviteetti: Konferenssiesitelmä

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Johanna Schleutker (Contributor)

  20 tammik. 2010

  Aktiviteetti: Konferenssiesitelmä

• Coeliac disease-specific IgA enhances the transepithelial passage of gliadin peptides without breaking the epithelial barrier

  T Rauhavirta (Contributor), K Kaukinen (Contributor), S-W Qiao (Contributor), IR Korponay-Szabo (Contributor), LM Sollid (Contributor), R Collighan (Contributor), A Mongeot (Contributor), M Griffin (Contributor), M Mäki (Contributor) & K Lindfors (Contributor)

  20 tammik. 2010

  Aktiviteetti: Konferenssiesitelmä

• Features of celiac diasease can be induced in mice by passive transfer of patient serum

  S Kalliokoski (Speaker), S Caja (Speaker), Ilma Korponay-Szabó (Speaker), O Koskinen (Speaker), M Mäki (Speaker), K Kaukinen (Speaker) & K Lindfors (Speaker)

  18 jouluk. 2009

  Aktiviteetti: Konferenssiesitelmä

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  L Airaksinen (Contributor), K Kaukinen (Contributor), J Schleutker (Contributor), M Mäki (Contributor) & K Lindfors (Contributor)

  16 jouluk. 2009

  Aktiviteetti: Konferenssiesitelmä

• Downregulation of transglutaminase and its implications for coeliac disease

  Cristina Nadalutti (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  16 jouluk. 2009

  Aktiviteetti: Konferenssiesitelmä

• Coeliac disease-specific IgA enhances the transepithelial passage of gliadin peptides without breaking the epithelial barrier

  Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  16 jouluk. 2009

  Aktiviteetti: Konferenssiesitelmä

• Coeliac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA

  E Myrsky (Contributor), S Caja (Contributor), Z Simon-Vecsei (Contributor), I Korponay-Szabo (Contributor), C Nadalutti (Contributor), R Collighan (Contributor), A Mongeot (Contributor), M Griffin (Contributor), M Mäki (Contributor), K Kaukinen (Contributor) & K Lindfors (Contributor)

  25 marrask. 2009

  Aktiviteetti: Konferenssiesitelmä

• Usefulness of small-bowel mucosal transglutaminase-2 specific IgA autonantibody deposits in coeliac disease diagnosis and follow-up

  Pekka Collin (Speaker), Katri Kaukinen (Speaker), Kaija Laurila (Speaker), Katri Lindfors (Speaker) & Markku Mäki (Speaker)

  25 marrask. 2009

  Aktiviteetti: Konferenssiesitelmä

• Downregulation of transglutaminase and its implications for coeliac disease

  Cristina Nadalutti (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  26 lokak. 2009

  Aktiviteetti: Konferenssiesitelmä

• Materno-fetal antibody transfer in coeliac disease

  Ilma Korponay-Szabó (Contributor), Sergio Caja Galan (Contributor), Kati Juuti-Uusitalo (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  3 lokak. 2009

  Aktiviteetti: Konferenssiesitelmä

• The transepithelial passage of gliadin peptides is enhanced in the presence of coeliac disease - specific IgA

  T Rauhavirta (Contributor), K Kaukinen (Contributor), IR Korponay-Szabo (Contributor), A Mongeot (Contributor), R Collighan (Contributor), M Griffin (Contributor), M Mäki (Contributor) & K. Lindfors (Contributor)

  10 syysk. 2009

  Aktiviteetti: Konferenssiesitelmä

• Downregulation of transglutaminase and its implications for coeliac disease

  C Nadalutti (Contributor), K Viiri (Contributor), K Kaukinen (Contributor), K Lindfors (Contributor) & M Mäki (Contributor)

  28 elok. 2009

  Aktiviteetti: Konferenssiesitelmä

• The autoantibodies anti-TG2 can modulate gene expression related with angiogenesis in endothelial cells

  S Martucciello (Contributor), S Caja (Contributor), M Mäki (Contributor), K Kaukinen (Contributor) & K Lindfors (Contributor)

  7 huhtik. 2009

  Aktiviteetti: Konferenssiesitelmä

• Coeliac disease-specific autoantibodies modulate vascular permeability in vitro

  E Myrsky (Contributor), S Caja Galan (Contributor), IR Korponay-Szabo (Contributor), R Collighan (Contributor), A Mongeot (Contributor), M Griffin (Contributor), M Mäki (Contributor), K Kaukinen (Contributor) & K Lindfors (Contributor)

  7 huhtik. 2009

  Aktiviteetti: Konferenssiesitelmä

• Usefulness of small-bowel mucosal transglutaminase-2 spesific IgA autoantibody deposits in coeliac disease diagnosis and follow-up

  Pekka Collin (Contributor), Katri Kaukinen (Contributor), Kaija Laurila (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  7 huhtik. 2009

  Aktiviteetti: Konferenssiesitelmä

• Downregulation of tissue transglutaminase and its implications for coeliac disease

  Cristina Nadalutti (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  7 huhtik. 2009

  Aktiviteetti: Konferenssiesitelmä

• Reducing the toxic effects of rye secalin by germinating cereal enzymes in vitro - implications for future therapeutics in coeliac disease

  S Stenman (Contributor), K Lindfors (Contributor), A Hautala (Contributor), J Venäläinen (Contributor), P Männistö (Contributor), A Kaukovirta-Norja (Contributor), M Mäki (Contributor) & K Kaukinen (Contributor)

  6 huhtik. 2009

  Aktiviteetti: Konferenssiesitelmä

• The transepithelial passage of gliadin peptides is enhanced in the presence of coeliac disease - specific IgA

  Tiina Rauhavirta (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  6 huhtik. 2009

  Aktiviteetti: Konferenssiesitelmä

• Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb vessel morphogenesis in vitro and in vivo through RhoB

  Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  6 huhtik. 2009

  Aktiviteetti: Konferenssiesitelmä

• Usefulness of small-bowel mucosal transglutaminase-2 specific IgA autoantibody deposits in celiac disease diagnosis and follow-up

  Pekka Collin (Contributor), Katri Kaukinen (Contributor), Kaija Laurila (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  19 maalisk. 2009

  Aktiviteetti: Konferenssiesitelmä

• Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in coeliac disease diagnosis and follow-up

  O Koskinen (Contributor), P Collin (Contributor), K Laurila (Contributor), K Lindfors (Contributor), M Mäki (Contributor) & K Kaukinen (Contributor)

  12 helmik. 2009

  Aktiviteetti: Konferenssiesitelmä

• Oats and celiac disease – study of oats-derived compounds in vitro

  Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  23 tammik. 2009

  Aktiviteetti: Konferenssiesitelmä